Yale scientists have developed a new CRISPR tool, CRISPR-Cas12a, which allows for more seamless gene editing and the simultaneous assessment of multiple genetic changes. This advancement enables researchers to study complex genetic interactions and their effects on various diseases, including cancer. The new tool also facilitates the rapid generation of disease and treatment models, offering valuable insights for developing new therapies.